ISSN 1016-5169 | E-ISSN 1308-4488
Archives of the Turkish Society of Cardiology
pdf
Lichenoid type cutaneous hyperpigmentation induced by nebivolol [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2017; 45(3): 268-270 | DOI: 10.5543/tkda.2016.02151

Lichenoid type cutaneous hyperpigmentation induced by nebivolol

Abdullah Nabi Aslan1, Murat Can Güney2, Murat Akçay2, Telat Keleş2, Engin Bozkurt2
1Ataturk Education And Research Hospital, Department Of Cardiology,ankara
2Yıldırım Beyazıt University Faculty Of Medicine,department Of Cardiology,ankara

Cutaneous hyperpigmentation is a common and well-defined side effect of many drugs, such as non-steroidal anti-inflammatory drugs, beta-blockers, and tetracyclines, but to the best of our knowledge there is no case of skin discoloration related to nebivolol in the literature. Presently described is lichenoid type cutaneous hyperpigmentation in a 46-year-old female patient. Hyperpigmentation emerged 3 months after initiating use of nebivolol and resolved after cessation of drug use. It was concluded that effect emerged as result of therapeutic doses of nebivolol.

Keywords: Beta-blocker, cutaneous hyperpigmentation, lichenoid, nebivolol; side effect.

How to cite this article
Abdullah Nabi Aslan, Murat Can Güney, Murat Akçay, Telat Keleş, Engin Bozkurt. Lichenoid type cutaneous hyperpigmentation induced by nebivolol. Turk Kardiyol Dern Ars. 2017; 45(3): 268-270

Corresponding Author: Abdullah Nabi Aslan, Türkiye
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.